Literature DB >> 8466709

Increased inositol 1,4,5-trisphosphate binding capacity in vascular smooth muscle of spontaneously hypertensive rats.

S Bernier1, G Guillemette.   

Abstract

High intracellular levels of free calcium (Ca2+) are found in cells of hypertensive patients, and these levels have been correlated with increased blood pressure. In the present study, we characterized inositol 1,4,5-trisphosphate (InsP3) receptors in aorta and heart microsomes of Long-Evans rats. We also studied this receptor in some organs of spontaneously hypertensive rats (SHR) to clarify the role this important component of the mechanism of Ca2+ regulation has in hypertension. Microsomal fractions were prepared from aorta, heart, adrenal cortex (organs directly involved in the regulation of blood pressure), and cerebellum (control organ, not directly involved) of 14-week-old SHR and Wistar-Kyoto (WKY) rats. InsP3, receptors were studied in each microsomal fraction by a radioligand binding method with [3H]InsP3. The properties of InsP3 binding sites in each tissue were consistent with those of well-characterized InsP3 receptors: 1) InsP3 binding was specific and saturable, 2) InsP3 binding increased upon pH elevation, 3) InsP3 binding was inhibited by heparin, and 4) InsP3 had a higher binding affinity than InsP4. No significant difference of binding affinity or of maximal binding capacity between WKY and SHR was observed in microsomes from heart, adrenal cortex, and cerebellum. It is interesting that InsP3 binding capacity of SHR aorta microsomes was significantly higher (1.6 fold) than that of WKY aorta microsomes. These results suggest that increased InsP3 receptor activity in vascular smooth muscle of SHR may contribute to the elevation of blood pressure. Further studies are needed to assess the significance of this observation as regards the mobilization of intracellular Ca2+.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8466709

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  7 in total

Review 1.  Inositol trisphosphate receptors in smooth muscle cells.

Authors:  Damodaran Narayanan; Adebowale Adebiyi; Jonathan H Jaggar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-23       Impact factor: 4.733

Review 2.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

3.  Inositol 1,4,5-trisphosphate (IP3) receptor up-regulation in hypertension is associated with sensitization of Ca2+ release and vascular smooth muscle contractility.

Authors:  Haissam Abou-Saleh; Asif R Pathan; Arwa Daalis; Satanay Hubrack; Hamda Abou-Jassoum; Hamda Al-Naeimi; Nancy J Rusch; Khaled Machaca
Journal:  J Biol Chem       Date:  2013-10-04       Impact factor: 5.157

Review 4.  Regulation of cerebral artery smooth muscle membrane potential by Ca²⁺-activated cation channels.

Authors:  Albert L Gonzales; Scott Earley
Journal:  Microcirculation       Date:  2013-05       Impact factor: 2.628

5.  Changes in IP3 Receptor Expression and Function in Aortic Smooth Muscle of Atherosclerotic Mice.

Authors:  Marie-Ann Ewart; Azizah Ugusman; Anisha Vishwanath; Tarek A M Almabrouk; Husam Alganga; Omar J Katwan; Pavlina Hubanova; Susan Currie; Simon Kennedy
Journal:  J Vasc Res       Date:  2017-04-01       Impact factor: 1.934

Review 6.  Inositol 1,4,5-Trisphosphate Receptors in Hypertension.

Authors:  Ali H Eid; Ahmed F El-Yazbi; Fouad Zouein; Abdelilah Arredouani; Allal Ouhtit; Md M Rahman; Hatem Zayed; Gianfranco Pintus; Haissam Abou-Saleh
Journal:  Front Physiol       Date:  2018-07-26       Impact factor: 4.566

7.  The effect of intrauterine growth restriction on Ca2+ -activated force and contractile protein expression in the mesenteric artery of adult (6-month-old) male and female Wistar-Kyoto rats.

Authors:  Michael J Christie; Tania Romano; Robyn M Murphy; Giuseppe S Posterino
Journal:  Physiol Rep       Date:  2018-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.